These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 26564155

  • 1. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 2. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
    Ferraro PM, Ferraccioli GF, Gambaro G, Fulignati P, Costanzi S.
    Nephrol Dial Transplant; 2009 Jan; 24(1):156-60. PubMed ID: 18685141
    [Abstract] [Full Text] [Related]

  • 3. Retrospective Analysis of Clinical Outcomes in Patients with Immunoglobulin A Nephropathy and Persistent Hematuria Following Renin-Angiotensin System Blockade.
    Chen J, Liu S, Xu H, Wang W, Xie Y, Tang W, Yuan Q, Zheng L, Lin L, Fu S, Shen J.
    Med Sci Monit; 2020 Aug 21; 26():e922839. PubMed ID: 32822333
    [Abstract] [Full Text] [Related]

  • 4. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar 21; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 5. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF, VA NEPHRON-D Study Group.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2159-69. PubMed ID: 26482258
    [Abstract] [Full Text] [Related]

  • 6. Primary IgA nephropathy in elderly patients.
    Cheungpasitporn W, Nasr SH, Thongprayoon C, Mao MA, Qian Q.
    Nephrology (Carlton); 2015 Jun 07; 20(6):419-25. PubMed ID: 25726845
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, Hirakata H, Tsuruya K, Kitazono T.
    Clin J Am Soc Nephrol; 2013 Dec 07; 8(12):2082-90. PubMed ID: 24178970
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Dec 07; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 9. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.
    Kwok T, Leung J, Barrett-Connor E, Osteoporotic Fractures in Men (MrOS) Research Group.
    Age Ageing; 2017 Jan 10; 46(1):57-64. PubMed ID: 28181652
    [Abstract] [Full Text] [Related]

  • 10. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y, Sun L, Zhou S, Xu Q, Xu Q, Liu D, Liu L, Hu R, Quan S, Xing G.
    Kidney Blood Press Res; 2018 Jan 10; 43(2):639-650. PubMed ID: 29698975
    [Abstract] [Full Text] [Related]

  • 11. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 12. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Mar 14; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 13. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017 Mar 14; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 14. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.
    Am J Kidney Dis; 2000 Jun 14; 35(6):1155-65. PubMed ID: 10845831
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
    Omae K, Ogawa T, Nitta K.
    Heart Vessels; 2010 May 14; 25(3):203-8. PubMed ID: 20512447
    [Abstract] [Full Text] [Related]

  • 16. Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney Disease.
    Wu PC, Wu CJ, Lin CJ, Pan CF, Chen CY, Huang TM, Wu CH, Lin SL, Chen YM, Chen L, Wu VC, NSARF Group, Kidney Consortium.
    Clin Pharmacol Ther; 2015 Oct 14; 98(4):442-9. PubMed ID: 26082272
    [Abstract] [Full Text] [Related]

  • 17. The effects of cytotoxic therapy in progressive IgA nephropathy.
    Shin JH, Lee JE, Park JH, Lim S, Jang HR, Kwon GY, Huh W, Jung SH, Kim YG, Oh HY, Kim DJ.
    Ann Med; 2016 Oct 14; 48(3):171-81. PubMed ID: 27031662
    [Abstract] [Full Text] [Related]

  • 18. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2017 Aug 14; 21(4):617-623. PubMed ID: 27549901
    [Abstract] [Full Text] [Related]

  • 19. The beneficial effects of renin-angiotensin system blockades on 2 year outcomes in coronary artery ectasia patients.
    Wang Y, Wang Y, Yin D, Dou K, Wu Y, Song W.
    Curr Med Res Opin; 2017 Sep 14; 33(9):1677-1684. PubMed ID: 28598221
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 14; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.